Research location

Belleville

New Jersey, United States

Published trials43

Site observations44

Linked trials published43

Page1 / 1

Research activity in Belleville

New Jersey, United States

CureCurrent currently publishes aggregate city-level research activity for this location: 43 trials and 44 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Belleville

43 linked trials · page 1 of 1

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)NCT07144280 · 2025-09-29 · 1 site observation

DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-AdjustmentNCT07158164 · 2025-08-27 · 1 site observation

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung CancerNCT06892548 · 2025-05-02 · 1 site observation

RADIANT: Pre-op Radiation With Abemaciclib and LetrozoleNCT06139107 · 2024-08-22 · 1 site observation

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 MutationNCT05696626 · 2023-10-31 · 1 site observation

A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine TherapyNCT05774951 · 2023-03-31 · 1 site observation

GEMINI-NSCLC: NSCLC Biomarker StudyNCT05236114 · 2022-06-22 · 1 site observation

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7NCT04613596 · 2020-12-02 · 1 site observation

Pilot Trial of Preop Partial Radiation in Breast Cancer PatientsNCT07178665 · 2025-09-02 · 1 site observation

Gut and Tumor Microbiome in Patients With Early Stage (II-III), Locally Advanced or Advanced ER-positive and HER2-negative Breast Cancer.NCT06126003 · 2023-12-01 · 1 site observation

Study to Compare Furmonertinib to Platinum-Based Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations (FURVENT)NCT05607550 · 2023-06-01 · 1 site observation

ACTIVE_NOT_RECRUITING

Niraparib in the Treatment of Patients With Advanced PALB2 Mutated TumorsNCT05169437 · 2022-03-15 · 1 site observation

Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)NCT05103358 · 2022-03-10 · 1 site observation

Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance TrialNCT05050084 · 2021-12-06 · 1 site observation

ACTIVE_NOT_RECRUITING

A Study to Examine the Efficacy and Safety of Anti-Fel d 1 Antibodies Injections in Cat-allergic Adolescent and Adult Patients With Allergic Rhinitis Who Live With a CatNCT04981717 · 2021-07-30 · 1 site observation

Radiation Therapy Boost Before Surgery for the Treatment of Non-metastatic Breast CancerNCT04871516 · 2021-05-18 · 1 site observation

ACTIVE_NOT_RECRUITING

Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPCNCT04821622 · 2021-05-12 · 1 site observation

ACTIVE_NOT_RECRUITING

LIQUIK: LIQUId Biopsy for Detection of Actionable Genomic BiomarKers in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)NCT04703153 · 2021-04-05 · 1 site observation

Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT TrialNCT04513717 · 2021-01-21 · 1 site observation

ACTIVE_NOT_RECRUITING

Evaluation of Lasofoxifene Combined With Abemaciclib in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 MutationNCT04432454 · 2020-09-29 · 1 site observation

KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLCNCT04265534 · 2020-07-24 · 1 site observation

Evaluation of Lasofoxifene Versus Fulvestrant in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 MutationNCT03781063 · 2019-09-20 · 1 site observation

A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)NCT03940703 · 2019-09-19 · 1 site observation

Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPCNCT03395197 · 2017-12-18 · 2 site observations

ACTIVE_NOT_RECRUITING

An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced CancersNCT02869789 · 2016-10-05 · 1 site observation

Clinical Effectiveness Assessment of VeriStrat® Testing and Validation of Immunotherapy Tests in NSCLC SubjectsNCT03289780 · 2016-04-04 · 1 site observation

ACTIVE_NOT_RECRUITING

Concordance of Key Actionable Genomic Alterations as Assessed in Tumor Tissue and Plasma in Non Small Cell Lung CancerNCT02762877 · 2016-04-01 · 1 site observation

Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective RegistryNCT02670577 · 2015-11-01 · 1 site observation

Study of Reslizumab in Participants With Uncontrolled Asthma and Elevated Blood EosinophilsNCT02452190 · 2015-09-28 · 1 site observation

Pharmacokinetic and Safety Study of Lower Doses of Ceritinib Taken With a Low-fat Meal Versus 750 mg of Ceritinib in the Fasted State in Adult Patients With (ALK-positive) Metastatic Non-small Cell Lung Cancer (NSCLC)NCT02299505 · 2015-04-09 · 1 site observation

Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)NCT02380274 · 2015-03-27 · 1 site observation

Albumin-bound Paclitaxel (ABI-007) for Patients With Advanced Non-Small Cell Lung CancerNCT00540514 · 2007-11-01 · 1 site observation

Phase 2b Study of Taxol Plus Sorafenib or Placebo in Patients With Advanced Breast CancerNCT00499525 · 2007-06-01 · 1 site observation

Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular SafetyNCT00359801 · 2006-07-01 · 1 site observation

Study Comparing VERSAJET With Conventional Surgical Procedures in the Removal of Unhealthy Tissue From Lower Limb UlcersNCT00521027 · 2006-04-01 · 1 site observation

A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.NCT00269828 · 2005-12-01 · 1 site observation

Comparison of Safety and Efficacy of TOCOSOL(R) Paclitaxel Versus Taxol(R) for Treatment of Metastatic Breast CancerNCT00251095 · 2005-09-01 · 1 site observation

A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)NCT00091663 · 2004-08-01 · 1 site observation

Study Evaluating CCI-779 and Letrozole in Post-menopausal Women With Breast CancerNCT00083993 · 2004-05-01 · 1 site observation

Iressa Expanded Access Program (EAP)NCT00034879 · 2000-08-01 · 1 site observation

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Small Cell Lung CancerNCT00006458 · 2000-08-01 · 1 site observation

Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung CancerNCT00006347 · 2000-08-01 · 1 site observation

Radioimmunotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast CancerNCT00004085 · 1998-05-01 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.